The era of the COVID-19 pandemic has amplified the increasing need for telemedicine’s accessibility in healthcare, particularly for the elderly, while serving as a catalyst for improvements in remote healthcare delivery services. The high susceptibility of older adults to the adverse effects of the COVID-19 virus makes the progression of their healthcare services toward virtual administration especially urgent. The prominence of cognitive impairment in older adults during the era of COVID-19 has called for the adaptation of established cognitive assessment tools for telemedicine. Many of these modified cognitive screening instruments, including the T-MoCA, TMMSE, and TICS-M have been found to be equally as reliable as their in-person cognitive assessment counterparts. Other reports identify the limitations of cognitive assessment tools following adaptation for telemedicine that must be considered during the diagnostic process.